PEAK6 Group’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$262K Buy
+11,800
New +$241K ﹤0.01% 3141
2017
Q4
Sell
-2,400
Closed -$41K 4058
2017
Q3
$41K Buy
+2,400
New +$40.3K ﹤0.01% 4063
2015
Q1
Sell
-3,200
Closed -$61K 4709
2014
Q4
$61K Sell
3,200
-5,900
-65% -$100K ﹤0.01% 4058
2014
Q3
$125K Buy
9,100
+4,200
+86% +$59.9K ﹤0.01% 3646
2014
Q2
$80K Buy
+4,900
New +$70.9K ﹤0.01% 3837

Other funds holding ANGO

PEAK6 Group's ANGO Position: Q2 2018 in Review

PEAK6 Group opened a new position in AngioDynamics (ANGO) in Q2 2018: 105 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #4197 among its holdings. This is a return to the name: PEAK6 Group previously reported a position in ANGO as recently as Q3 2017.

PEAK6 Group first reported a position in ANGO in Q1 2014 and has held it in 8 quarters since. The position peaked at $1.32M in Q4 2014. 174 funds tracked by Wall St. Rank hold ANGO as of Q2 2018.

  • PEAK6 Group held 105 shares of AngioDynamics worth $2K as of Q2 2018.
  • AngioDynamics was a new PEAK6 Group position in Q2 2018.
  • AngioDynamics made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #4197 holding.
  • PEAK6 Group first reported a position in AngioDynamics in Q1 2014 and has held it in 8 quarters since.
  • PEAK6 Group's AngioDynamics position peaked at $1.32M in Q4 2014.
  • 174 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.